Dollard des Ormeaux, Canada

Chun-Sing Li


Average Co-Inventor Count = 4.7

ph-index = 5

Forward Citations = 601(Granted Patents)


Location History:

  • Kirkland, CA (1999)
  • Dollard Des Ormeaux, CA (1995 - 2002)

Company Filing History:


Years Active: 1995-2002

Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Chun-Sing Li

Introduction

Chun-Sing Li is a notable inventor based in Dollard des Ormeaux, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases. With a total of 9 patents to his name, his work has had a meaningful impact on medical research and treatment options.

Latest Patents

Among his latest patents, Chun-Sing Li has developed innovative compounds such as "Pyrones as inhibitors of cyclooxygenase-2" and "Diphenyl-1,2,3-thiadiazol-3-oxides." These inventions encompass compounds of Formula I and include methods for treating COX-2 mediated diseases. The treatment involves administering a non-toxic therapeutically effective amount of a compound of Formula I to patients in need.

Career Highlights

Chun-Sing Li has worked with prominent companies in the pharmaceutical industry, including Merck Frosst Canada, Inc. and Merck Frosst Canada & Co. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in drug development.

Collaborations

Throughout his career, Chun-Sing Li has collaborated with esteemed colleagues such as Michel Therien and Jacques Yves Gauthier. These partnerships have fostered an environment of innovation and have led to the successful development of various pharmaceutical compounds.

Conclusion

Chun-Sing Li's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence medical research and treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…